Halozyme Therapeutics Inc (HALO)
63.84
-1.00
(-1.54%)
USD |
NASDAQ |
Mar 26, 16:00
63.84
0.00 (0.00%)
After-Hours: 18:40
Halozyme Therapeutics Market Cap: 7.862B for March 26, 2025
View 4,000+ Financial Data Types:
Add
Browse
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Biomarin Pharmaceutical Inc | 13.64B |
| Johnson & Johnson | 389.72B |
| Catalyst Pharmaceuticals Inc | 3.056B |
| Merck & Co Inc | 222.64B |
| Semler Scientific Inc | 379.93M |
Market Cap Related Metrics
| PE Ratio | 18.61 |
| PS Ratio | 8.132 |
| PEG Ratio | 0.2975 |
| Price to Book Value | 21.61 |
| Price to Free Cash Flow | 17.63 |
| Price | 63.84 |
| Earnings Yield | 5.37% |
| PEGY Ratio | 0.2975 |
| Operating PE Ratio | 14.97 |
| Normalized PE Ratio | 19.44 |